These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6318993)

  • 1. Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol.
    Gralla RJ; Tyson LB; Bordin LA; Clark RA; Kelsen DP; Kris MG; Kalman LB; Groshen S
    Cancer Treat Rep; 1984 Jan; 68(1):163-72. PubMed ID: 6318993
    [No Abstract]   [Full Text] [Related]  

  • 2. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy.
    Colls BM; Ferry DG; Gray AJ; Harvey VJ; McQueen EG
    N Z Med J; 1980 Jun; 91(662):449-51. PubMed ID: 6250106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
    Drug Ther Bull; 1984 Feb; 22(3):9-11. PubMed ID: 6321126
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.
    Sallan SE; Cronin C; Zelen M; Zinberg NE
    N Engl J Med; 1980 Jan; 302(3):135-8. PubMed ID: 6985702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metoclopramide (Primperan) versus droperidol (Dridol) as an antiemetic in intravenous cancer chemotherapy].
    Melsom H; Nandrup E; Monge OR
    Tidsskr Nor Laegeforen; 1982 Jun; 102(16):914-5. PubMed ID: 6761895
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vomiting accompanying cytostatic treatment, and its control].
    Kotlarek-Haus S; Orzechowska-Juzwenko K; Gabryś K
    Pol Tyg Lek; 1984 Nov; 39(47):1555-9. PubMed ID: 6151174
    [No Abstract]   [Full Text] [Related]  

  • 7. Nabilone and other antiemetics for cancer patients.
    Med Lett Drugs Ther; 1988 Jan; 30(756):2-4. PubMed ID: 2826977
    [No Abstract]   [Full Text] [Related]  

  • 8. Metoclopramide as an antiemetic in chemotherapy.
    N Engl J Med; 1982 Jul; 307(4):249-51. PubMed ID: 7045663
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiemetic therapy in patients treated with cisplatin chemotherapy.
    Roila F; Basurto C; Bracarda S; Del Favero A; Tonato M
    J Chemother; 1989 Jul; 1(4 Suppl):1281-5. PubMed ID: 16312866
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of cytostatic-induced vomiting. High-dosage metoclopramide versus an antiemetic combination in a controlled comparison].
    Ell C; König HJ; Gutmann W; Domschke S; Domschke W
    Med Welt; 1983 Sep; 34(35):945-8. PubMed ID: 6355746
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacotherapy of emesis caused by cytostatic agents].
    Baggerman C
    Ned Tijdschr Geneeskd; 1982 May; 126(18):803-7. PubMed ID: 6283396
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
    Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
    Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of antiemetics for vomiting due to cancer chemotherapy in children].
    Ise T; Ohira M; Omiya A; Hirose M; Shibata T
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1108-18. PubMed ID: 6764113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies of oral antiemetic drugs on delayed emesis induced by cancer chemotherapy].
    Sawaguchi K; Yabushita H; Tsukada H; Yamada H; Noguchi M; Nakanishi M
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):117-23. PubMed ID: 9987507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
    Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of antiemetic properties of clebopride and metoclopramide in vomiting produced by cis-platinum (author's transl)].
    Padrón F; Sanz J; Flórez J
    Med Clin (Barc); 1981 Sep; 77(4):167-70. PubMed ID: 7031384
    [No Abstract]   [Full Text] [Related]  

  • 20. Tetrahydrocannabinol as an antiemetic for cancer patients.
    Earhart RH; Buchanan-Davidson DJ
    Wis Med J; 1980 Mar; 79(3):47-8. PubMed ID: 6244707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.